Novavax, Inc.Long
NOVAVAX - Nasdaq +30% - strong uptrend
Novavax collabora con MODERNA inc allosviluppo del vaccino anti-COVID. Target 37.40, chiusura gap-down del 21.02.19
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.